Applying whole-genome studies of epigenetic regulation to study human disease

Cytogenetic and Genome Research

Volumn 114, Issue 1, 2006, Pages 1-15

  Lieb, J D ^a   Beck, S ^b   Bulyk, M L ^c   Farnham, P ^d   Hattori, N ^e   Henikoff, S ^f   Liu, X S ^g   Okumura, K ^h   Shiota, K ^e   Ushijima, T ⁱ   Greally, J M ^j  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TOKYO   (Japan)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h MIE UNIVERSITY   (Japan)

ⁱ NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^j ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC AGENT; CYTOSINE; ENZYME; PROTEIN; TRANSCRIPTION FACTOR; ZEBULARINE;

CANCER GENETICS; CHROMATIN; DEVELOPMENTAL DISORDER; DNA BINDING MOTIF; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; ENZYME LOCALIZATION; EPIGENETICS; GENE MAPPING; GENETIC DISORDER; GENETIC REGULATION; GENOME ANALYSIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEOSOME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MOTIF; REVIEW; GENE EXPRESSION REGULATION; GENETICS; GENOME; GENOMICS; METHODOLOGY;

GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; GENOME, HUMAN; GENOMICS; HUMANS;

EID: 33744976344     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091922     Document Type: Review

References (200)

1. Abe M, Ohira M, Kaneda A, Yagi Y, Yamamoto S, Kitano Y, Takato T, Nakagawara A, Ushijima T: CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Res 65:828-834 (2005).
2. Antequera F, Bird A: Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA 90:11995-11999 (1993).
3. Bailey TL, Elkan CP: Fitting a mixture model by expectation-maximization to discover motifs in biopolymers. ISMB:28-36 (1994).
4. Belinsky SA: Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4:707-717(2004).
5. Bell AC, Felsenfeld G: Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405:482-485 (2000).
6. Ben-Porath I, Cedar H: Epigenetic crosstalk. Mol Cell 8:933-935 (2001).
7. Ben-Yehuda S, Fujita M, Liu XS, Gorbatyuk B, Skoko D, Yan J, Marko JF, Liu JS, Eichenberger P, Rudner DZ, et al: Defining a centromere-like element in Bacillus subtilis by identifying the binding sites for the chromosome-anchoring protein RacA. Mol Cell 17:773-782 (2005).
8. Bernstein BE, Humphrey EL, Erlich RL, Schneider R, Bouman P, Liu JS, Kouzarides T, Schreiber SL: Methylation of histone H3 Lys 4 in coding regions of active genes. Proc Natl Acad Sci USA 99:8695-8700 (2002).
9. Bernstein BE, Humphrey EL, Liu CL, Schreiber SL: The use of chromatin immunoprecipitation assays in genome-wide analyses of histone modifications. Meth Enzymol 376:349-360 (2004a).
10. Bernstein BE, Liu CL, Humphrey EL, Perlstein EO, Schreiber SL: Global nucleosome occupancy in yeast. Genome Biol 5:R62 (2004b).
11. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, McMahon S, Karlsson EK, Kulbokas EJ 3rd, Gingeras TR, et al: Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120:169-181 (2005).
12. Bestor TH: The DNA methyltransferases of mammals. Hum Mol Genet 9:2395-2402 (2000).
13. Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H: Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151 (1990).
14. Boguski MS: ENCODE and ChIP-chip in the genome era. Genomics 83:347-348 (2004).
15. Bradbury J: Human epigenome project-up and running. PLoS Biol 1:E82 (2003).
16. Brenner S, Johnson M, Bridgham J, Golda G, Lloyd DH, Johnson D, Luo S, McCurdy S, Foy M, Ewan M, et al: Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol 18:630-634 (2000).
17. Buck MJ, Lieb JD: ChIP-chip: considerations for the design, analysis, and application of genome-wide chromatin immunoprecipitation experiments. Genomics 83:349-360 (2004).
18. Bulyk ML: Computational prediction of transcription-factor binding site locations. Genome Biol 5:201 (2003).
19. Bulyk ML, Huang X, Choo Y, Church GM: Exploring the DNA-binding specificities of zinc fingers with DNA microarrays. Proc Natl Acad Sci USA 98:7158-7163 (2001).
20. Bussemaker HJ, Li H, Siggia ED: Regulatory element detection using correlation with expression. Nat Genet 27:167-171. (2001).
21. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, et al: Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122:33-43 (2005).
22. Carter D, Chakalova L, Osborne CS, Dai YF, Fraser P: Long-range chromatin regulatory interactions in vivo. Nat Genet 32:623-626 (2002).
23. Casolari JM, Brown CR, Komili S, West J, Hieronymus H, Silver PA: Genome-wide localization of the nuclear transport machinery couples transcriptional status and nuclear organization. Cell 117:427-439 (2004).
24. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ, et al: Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116:499-509 (2004).
25. Chen J, Sadowski I: Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements. Proc Natl Acad Sci USA 102:4813-4818 (2005).
26. Cheng JC, Yoo CB, Weisenberger DJ, Chuang J, Wozniak C, Liang G, Marquez VE, Greer S, Orntoft TF, Thykjaer T, et al: Preferential response of cancer cells to zebularine. Cancer Cell 6:151-158 (2004).
27. Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S, Patel S, Long J, Stern D, Tammana H, Helt G, et al: Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 308:1149-1154 (2005).
28. Ching TT, Maunakea AK, Jun P, Hong C, Zardo G, Pinkel D, Albertson DG, Fridlyand J, Mao JH, Shchors K, et al: Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nat Genetics 37:645-651 (2005).
29. Cho JH, Kimura H, Minami T, Ohgane J, Hattori N, Tanaka S, Shiota K: DNA methylation regulates placental lactogen I gene expression. Endocrinology 142:3389-3396 (2001).
30. Clark SJ, Harrison J, Frommer M: CpNpG methylation in mammalian cells. Nat Genet 10:20-27 (1995).
31. Conlon EM, Liu XS, Lieb JD, Liu JS: Integrating regulatory motif discovery and genome-wide expression analysis. Proc Natl Acad Sci USA 100:3339-3344 (2003).
32. Cosma MP, Tanaka T, Nasmyth K: Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell 97:299-311 (1999).
33. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR, Feinberg AP: Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299:1753-1755 (2003).
34. De Smet C, Lurquin C, Lethe B, Martelange V, Boon T: DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 19:7327-7335 (1999).
35. De Smet C, Loriot A, Boon T: Promoter-dependent mechanism leading to selective hypomethylation within the 5′ region of gene MAGE-A1 in tumor cells. Mol Cell Biol 24:4781-4790 (2004).
36. Dekker J, Rippe K, Dekker M, Kleckner N: Capturing chromosome conformation. Science 295:1306-1311 (2002).
37. Dion MF, Altschuler SJ, Wu LF, Rando OJ: Genomic characterization reveals a simple histone H4 acetylation code. Proc Natl Acad Sci USA 102:5501-5506 (2005).
38. Dorschner MO, Hawrylycz M, Humbert R, Wallace JC, Shafer A, Kawamoto J, Mack J, Hall R, Goldy J, Sabo PJ, et al: High-throughput localization of functional elements by quantitative chromatin profiling. Nat Methods 1:219-225 (2004).
39. Editorial: Getting hip to the chip. Nat Genet 18:195-197 (1998).
40. Egger G, Liang G, Aparicio A, Jones PA: Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457-463 (2004).
41. El-Osta A, Wolffe AP: DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease. Gene Expr 9:63-75 (2000).
42. ENCODE Project Consortium: The ENCODE (EN-Cyclopedia Of DNA Elements) Project. Science 306:636-640 (2004).
43. 6-methylguanine DNA methyltransferase in human cancer. Oncogene 23:1-8 (2004).
44. Euskirchen G, Royce TE, Bertone P, Martone R, Rinn JL, Nelson FK, Sayward F, Luscombe NM, Miller P, Gerstein M, et al: CREB binds to multiple loci on human chromosome 22. Mol Cell Biol 24:3804-3814 (2004).
45. Farnham PJ: In vivo assays to examine transcription factor localization and target gene specificity. Methods 26:1-2 (2002).
46. Fazzari MJ, Greally JM: Epigenomics: beyond CpG islands. Nat Rev Genet 5:446-455 (2004).
47. Feinberg AP, Tycko B: The history of cancer epigenetics. Nat Rev Cancer 4:143-153 (2004).
48. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suner D, Cigudosa JC, Urioste M, Benitez J, et al: Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102:10604-10609 (2005).
49. Fried M, Crothers DM: Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res 9: 6505-6525 (1981).
50. Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H, Domann FE: Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet 31:175-179 (2002).
51. Gardiner-Garden M, Frommer M: CpG islands in vertebrate genomes. J Mol Biol 196:261-282 (1987).
52. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R: Induction of tumors in mice by genomic hypomethylation. Science 300:489-492 (2003).
53. Gilbert N, Boyle S, Fiegler H, Woodfine K, Carter NP, Bickmore WA: Chromatin architecture of the human genome: gene-rich domains are enriched in open chromatin fibers. Cell 118:555-566 (2004).
54. Glynn EF, Megee PC, Yu HG, Mistrot C, Unal E, Koshland DE, DeRisi JL, Gerton JL: Genome-wide mapping of the cohesin complex in the yeast Saccharomyces cerevisiae. PLoS Biol 2:E259 (2004).
55. Gordon DB, Nekludova L, McCallum S, Fraenkel E: TAMO: a flexible, object-oriented framework for analyzing transcriptional regulation using DNA-sequence motifs. Bioinformatics 21:3164-3165 (2005).
56. Greally JM, Starr DJ, Hwang S, Song L, Jaarola M, Zemel S: The mouse H19 locus mediates a transition between imprinted and non-imprinted DNA replication patterns. Hum Mol Genet 7:91-96 (1998).
57. Greil F, van der Kraan I, Delrow J, Smothers JF, de Wit E, Bussemaker HJ, van Driel R, Henikoff S, van Steensel B: Distinct HP1 and Su(var)3-9 complexes bind to sets of developmentally coexpressed genes depending on chromosomal location. Genes Dev 17:2825-2838 (2003).
58. Grundy WN, Bailey TL, Elkan CP: ParaMEME: a parallel implementation and a web interface for a DNA and protein motif discovery tool. Comput Appl Biosci 12:303-310 (1996).
59. Guenther MG, Jenner RG, Chevalier B, Nakamura T, Croce CM, Canaani E, Young RA: Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci USA 102:8603-8608 (2005).
60. Hampsey M, Reinberg D: Tails of intrigue: phosphorylation of RNA polymerase II mediates histone methylation. Cell 113:429-432 (2003).
61. Hanlon SE, Lieb JD: Progress and challenges in profiling the dynamics of chromatin and transcription factor binding with DNA microarrays. Curr Opin Genet Dev 14:697-705 (2004).
62. Harbison CT, Gordon DB, Lee TI, Rinaldi NJ, Macisaac KD, Danford TW, Hannett NM, Tagne JB, Reynolds DB, Yoo J, et al: Transcriptional regulatory code of a eukaryotic genome. Nature 431:99-104 (2004).
63. Harikrishnan KN, Chow MZ, Baker EK, Pal S, Bassal S, Brasacchio D, Wang L, Craig JM, Jones PL, Sif S, et al: Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 37:254-264 (2005).
64. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM: CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405:486-489 (2000).
65. Hattori N, Nishino K, Ko YG, Hattori N, Ohgane J, Tanaka S, Shiota K: Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J Biol Chem 279: 17063-17069 (2004).
66. Horak CE, Snyder M: ChIP-chip: a genomic approach for identifying transcription factor binding sites. Methods Enzymol 350:469-483 (2002).
67. Horak CE, Mahajan MC, Luscombe NM, Gerstein M, Weissman SM, Snyder M: GATA-1 binding sites mapped in the beta-globin locus by using mammalian chIp-chip analysis. Proc Natl Acad Sci USA 99:2924-2929 (2002).
68. Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V, Polyak K: Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 37:899-905 (2005).
69. Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, Bennett HA, Coffey E, Dai H, He YD, et al: Functional discovery via a compendium of expression profiles. Cell 102: 109-126 (2000).
70. Humphrey EL, Shamji AF, Bernstein BE, Schreiber SL: Rpd3p relocation mediates a transcriptional response to rapamycin in yeast. Chem Biol 11: 295-299 (2004).
71. Im H, Grass JA, Johnson KD, Boyer ME, Wu J, Bresnick EH: Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation. Methods Mol Biol 284:129-146 (2004).
72. Imamura T, Ohgane J, Ito S, Ogawa T, Hattori N, Tanaka S, Shiota K: CpG island of rat sphingosine kinase-1 gene: tissue-dependent DNA methylation status and multiple alternative first exons. Genomics 76:117-125 (2001).
73. Imamura T, Miyauchi-Senda N, Tanaka S, Shiota K: Identification of genetic and epigenetic similarities of SPHK1/Sphk1 in mammals. J Vet Med Sci 66:1387-1393 (2004).
74. Impey S, McCorkle SR, Cha-Molstad H, Dwyer JM, Yochum GS, Boss JM, McWeeney S, Dunn JJ, Mandel G, Goodman RH: Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119:1041-1054 (2004).
75. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7:536-540 (1994).
76. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA: Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61:3573-3577 (2001).
77. Issa JP, Garcia-Manero G, Giles FJ, Mannari R, Thomas D, Faderl S, Bayar E, Lyons J, Rosenfeld CS, Cortes J, et al: Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies. Blood 103: 1635-1640 (2004).
78. Iyer VR, Horak CE, Scafe CS, Botstein D, Snyder M, Brown PO: Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature 409:533-538 (2001).
79. Jeffery L, Nakielny S: Components of the DNA methylation system of chromatin control are RNA-binding proteins. J Biol Chem 279:49479-49487 (2004).
80. Jenuwein T, Allis CD: Translating the histone code. Science 293:1074-1080 (2001).
81. Johnson KD, Bresnick EH: Dissecting long-range transcriptional mechanisms by chromatin immunoprecipitation. Methods 26:27-36 (2002).
82. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428 (2002).
83. Jones PA, Martienssen RA: Blueprint for a human epigenome project (HEP). Cancer Res 65:11241-11246 (2005).
84. Jorgensen HF, Bird A: MeCP2 and other methyl-CpG binding proteins. Ment Retard Dev Disabil Res Rev 8:87-93 (2002).
85. Kagotani K, Takebayashi S, Kohda A, Taguchi H, Paulsen M, Walter J, Reik W, Okumura K: Replication timing properties within the mouse distal chromosome 7 imprinting cluster. Biosci Biotechnol Biochem 66:1046-1051 (2002).
86. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R: Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808-811 (1997).
87. Kieser JA: Epigenetic canalization and phenotypic change: a minimax model. Med Hypotheses 22: 105-110 (1987).
88. Kim J, Bhinge AA, Morgan XC, Iyer VR: Mapping DNA-protein interactions in large genomes by sequence tag analysis of genomic enrichment. Nat Methods 2:47-53 (2005).
89. Kim TH, Barrera LO, Zheng M, Qu C, Singer MA, Richmond TA, Wu Y, Green RD, Ren B: A high-resolution map of active promoters in the human genome. Nature 436:876-880 (2005).
90. Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R: Male development of chromosomally female mice transgenic for Sry. Nature 351:117-121 (1991).
91. Kremenskoy M, Kremenska Y, Ohgane J, Hattori N, Tanaka S, Hashizume K, Shiota K: Genome-wide analysis of DNA methylation status of CpG islands in embryoid bodies, teratomas, and fetuses. Biochem Biophys Res Commun 311:884-890 (2003).
92. Kuo MH, Allis CD: In vivo cross-linking and immunoprecipitation for studying dynamic protein: DNA associations in a chromatin environment. Methods 19:425-433 (1999).
93. Kurdistani SK, Grunstein M: In vivo protein-protein and protein-DNA crosslinking for genomewide binding microarray. Methods 31:90-95 (2003).
94. Kurdistani SK, Robyr D, Tavazoie S, Grunstein M: Genome-wide binding map of the histone deacetylase Rpd3 in yeast. Nat Genet 31:248-254 (2002).
95. Kurdistani SK, Tavazoie S, Grunstein M: Mapping global histone acetylation patterns to gene expression. Cell 117:721-733 (2004).
96. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 3:253-266 (2003).
97. Lebrun E, Fourel G, Defossez PA, Gilson E: A methyltransferase targeting assay reveals silencer-telomere interactions in budding yeast. Mol Cell Biol 23:1498-1508 (2003).
98. Lee CK, Shibata Y, Rao B, Strahl BD, Lieb JD: Evidence for nucleosome depletion at active regulatory regions genome-wide. Nat Genet 36:900-905 (2004).
99. Lee TI, Young RA: Transcription of eukaryotic protein-coding genes. Annu Rev Genet 34:77-137 (2000).
100. Lee TI, Rinaldi NJ, Robert F, Odom DT, Bar-Joseph Z, Gerber GK, Hannett NM, Harbison CT, Thompson CM, Simon I, et al: Transcriptional regulatory networks in Saccharomyces cerevisiae. Science 298:799-804 (2002).
101. Lengronne A, Katou Y, Mori S, Yokobayashi S, Kelly GP, Itoh T, Watanabe Y, Shirahige K, Uhlmann F: Cohesin relocation from sites of chromosomal loading to places of convergent transcription. Nature 430:573-578 (2004).
102. Li E, Beard C, Jaenisch R: Role for DNA methylation in genomic imprinting. Nature 366:362-365 (1993).
103. Li W, Meyer CA, Liu XS: A hidden Markov model for analyzing ChIP-chip experiments on genome tiling arrays and its application to p53 binding sequences. Bioinformatics 21 Suppl 1:i274-i282 (2005).
104. Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B: A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 100:8164-8169 (2003).
105. Lieb JD: Genome-wide mapping of protein-DNA interactions by chromatin immunoprecipitation and DNA microarray hybridization. Methods Mol Biol 224:99-109 (2003).
106. Lieb JD, Liu X, Botstein D, Brown PO: Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. Nat Genet 28:327-334 (2001).
107. Lippman Z, Gendrel AV, Black M, Vaughn MW, Dedhia N, McCombie WR, Lavine K, Mittal V, May B, Kasschau KD, et al: Role of transposable elements in heterochromatin and epigenetic control. Nature 430:471-476 (2004).
108. Liu CL, Kaplan T, Kim M, Buratowski S, Schreiber SL, Friedman N, Rando OJ: Single-nucleosome mapping of histone modifications in S. cerevisiae. PLoS Biol 3:e328 (2005).
109. Liu X, Brutlag DL, Liu JS: BioProspector: discovering conserved DNA motifs in upstream regulatory regions of co-expressed genes. Pac Symp Biocomput:127-138 (2001).
110. Liu XS, Brutlag DL, Liu JS: An algorithm for finding protein-DNA binding sites with applications to chromatin-immunoprecipitation microarray experiments. Nat Biotechnol 20:835-839 (2002).
111. Liu X, Noll DM, Lieb JD, Clarke ND: DIP-chip: rapid and accurate determination of DNA-binding specificity. Genome Res 15:421-427 (2005).
112. Loden M, van Steensel B: Whole-genome views of chromatin structure. Chromosome Res 13:289-298 (2005).
113. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen YJ, Chen Z, et al: Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376-380 (2005).
114. Marks PA, Richon VM, Miller T, Kelly WK: Histone deacetylase inhibitors. Adv Cancer Res 91:137-168 (2004).
115. Marshall E: A strategy for sequencing the genome 5 years early. Science 267:783-784 (1995).
116. Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, Luscombe NM, Rinn JL, Nelson FK, Miller P, Gerstein M, et al: Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci USA 100:12247-12252 (2003).
117. Matsuyama T, Kimura MT, Koike K, Abe T, Nakano T, Asami T, Ebisuzaki T, Held WA, Yoshida S, Nagase H: Global methylation screening in the Arabidopsis thaliana and Mus musculus genome: applications of virtual image restriction landmark genomic scanning (Vi-RLGS). Nucleic Acids Res 31:4490-4496 (2003).
118. Mito Y, Henikoff JG, Henikoff S: Genome-scale profiling of histone H3.3 replacement patterns. Nat Genet 37:1090-1097 (2005).
119. Miyamoto K, Ushijima T: Diagnostic and therapeutic applications of epigenetics. Jpn J Clin Oncol 35:293-301 (2005).
120. Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T, Fujii Y, Takahashi T: Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers. Oncogene 21:2328-2333 (2002).
121. Mukherjee S, Berger MF, Jona G, Wang XS, Muzzey D, Snyder M, Young RA, Bulyk ML: Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays. Nat Genet 36:1331-1339 (2004).
122. Mukhopadhyay R, Yu W, Whitehead J, Xu J, Lezcano M, Pack S, Kanduri C, Kanduri M, Ginjala V, Vostrov A, et al: The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. Genome Res 14:1594-1602 (2004).
123. Murrell A, Rakyan VK, Beck S: From genome to epigenome. Hum Mol Genet 14 Spec No 1:R3-R10 (2005).
124. Nal B, Mohr E, Ferrier P: Location analysis of DNA-bound proteins at the whole-genome level: untangling transcriptional regulatory networks. Bioessays 23:473-476 (2001).
125. Newell-Price J, King P, Clark AJ: The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression. Mol Endocrinol 15:338-348 (2001).
126. Ng HH, Robert F, Young RA, Struhl K: Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol Cell 11: 709-719 (2003).
127. Ng P, Wei CL, Sung WK, Chiu KP, Lipovich L, Ang CC, Gupta S, Shahab A, Ridwan A, Wong CH, et al: Gene identification signature (GIS) analysis for transcriptome characterization and genome annotation. Nat Methods 2:105-111 (2005).
128. Ngo V, Gourdji D, Laverriere JN: Site-specific methylation of the rat prolactin and growth hormone promoters correlates with gene expression. Mol Cell Biol 16:3245-3254 (1996).
129. Nguyen CT, Gonzales FA, Jones PA: Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res 29:4598-4606 (2001).
130. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A: Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391 (1998).
131. Nishino K, Hattori N, Tanaka S, Shiota K: DNA methylation-mediated control of Sry gene expression in mouse gonadal development. J Biol Chem 279:22306-22313 (2004).
132. Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376 (2000).
133. Noble WS, Kuehn S, Thurman R, Yu M, Stamatoyannopoulos J: Predicting the in vivo signature of human gene regulatory sequences. Bioinformatics 21 Suppl 1:i338-i343 (2005).
134. Novik KL, Nimmrich I, Genc B, Maier S, Piepenbrock C, Olek A, Beck S: Epigenomics: genome-wide study of methylation phenomena. Curr Issues Mol Biol 4:111-128 (2002).
135. Oberley MJ, Farnham PJ: Probing chromatin immunoprecipitates with CpG-island microarrays to identify genomic sites occupied by DNA-binding proteins. Methods Enzymol 371:577-596 (2003).
136. Oberley MJ, Tsao J, Yau P, Farnham PJ: High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays. Methods Enzymol 376:315-334 (2004).
137. Ogura A, Inoue K, Ogonuki N, Noguchi A, Takano K, Nagano R, Suzuki O, Lee J, Ishino F, Matsuda J: Production of male cloned mice from fresh, cultured, and cryopreserved immature Sertoli cells. Biol Reprod 62:1579-1584 (2000).
138. Ohgane J, Aikawa J, Ogura A, Hattori N, Ogawa T, Shiota K: Analysis of CpG islands of trophoblast giant cells by restriction landmark genomic scanning. Dev Genet 22:132-140 (1998).
139. Ohgane J, Wakayama T, Kogo Y, Senda S, Hattori N, Tanaka S, Yanagimachi R, Shiota K: DNA methylation variation in cloned mice. Genesis 30:45-50 (2001).
140. Ohgane J, Wakayama T, Senda S, Yamazaki Y, Inoue K, Ogura A, Marh J, Tanaka S, Yanagimachi R, Shiota K: The Sal13 locus is an epigenetic hotspot of aberrant DNA methylation associated with placentomegaly of cloned mice. Genes Cells 9: 253-260 (2004).
141. Ohgane J, Hattori N, Shiota K: Analysis of tissue-specific DNA methylation during development. Methods Mol Biol 289:371-382 (2005).
142. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H: A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60:461-472 (1990).
143. Okazaki Y, Okuizumi H, Sasaki N, Ohsumi T, Kuromitsu J, Hirota N, Muramatsu M, Hayashizaki Y: An expanded system of restriction landmark genomic scanning (RLGS Ver. 1.8). Electrophoresis 16:197-202 (1995).
144. Okazawa H, Okamoto K, Ishino F, Ishino-Kaneko T, Takeda S, Toyoda Y, Muramatsu M, Hamada H: The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer. EMBO J 10:2997-3005 (1991).
145. Oliphant AR, Brandl CJ, Struhl K: Defining the sequence specificity of DNA-binding proteins by selecting binding sites from random-sequence oligonucleotides: analysis of yeast GCN4 protein. Mol Cell Biol 9:2944-2949 (1989).
146. Orlando V: Mapping chromosomal proteins in vivo by formaldehyde- crosslinked-chromatin immunoprecipitation. Trends Biochem Sci 25:99-104 (2000).
147. Pao MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA, Jones PA: The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. Hum Mol Genet 10:903-910 (2001).
148. Philippakis AA, He FS, Bulyk ML: Modulefinder: a tool for computational discovery of cis regulatory modules. Pac Symp Biocomput:519-530 (2005).
149. Rakyan VK, Hildmann T, Novik KL, Lewin J, Tost J, Cox AV, Andrews TD, Howe KL, Otto T, Olek A, et al: DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project. PLoS Biol 2:e405 (2004).
150. Ren B, Robert F, Wyrick JJ, Aparicio O, Jennings EG, Simon I, Zeitlinger J, Schreiber J, Hannett N, Kanin E, et al: Genome-wide location and function of DNA binding proteins. Science 290:2306-2309 (2000).
151. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD: E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16:245-256 (2002).
152. Robert F, Pokholok DK, Hannett NM, Rinaldi NJ, Chandy M, Rolfe A, Workman JL, Gifford DK, Young RA: Global position and recruitment of HATs and HDACs in the yeast genome. Mol Cell 16:199-209 (2004).
153. Robyr D, Suka Y, Xenarios I, Kurdistani SK, Wang A, Suka N, Grunstein M: Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases. Cell 109:437-446 (2002).
154. Robyr D, Kurdistani SK, Grunstein M: Analysis of genome-wide histone acetylation state and enzyme binding using DNA microarrays. Methods Enzymol 376:289-304 (2004).
155. Roh TY, Ngau WC, Cui K, Landsman D, Zhao K: High-resolution genome-wide mapping of histone modifications. Nat Biotechnol 22:1013-1016 (2004).
156. Roh TY, Cuddapah S, Zhao K: Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev 19:542-552 (2005).
157. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, Staudt LM: A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345:686-692 (1990).
158. Roth FP, Hughes JD, Estep PW, Church GM: Finding DNA regulatory motifs within unaligned noncoding sequences clustered by whole-genome mRNA quantitation. Nat Biotechnol 16:939-945 (1998).
159. Sabo PJ, Humbert R, Hawrylycz M, Wallace JC, Dorschner MO, McArthur M, Stamatoyannopoulos JA: Genome-wide identification of DNaseI hypersensitive sites using active chromatin sequence libraries. Proc Natl Acad Sci USA 101:4537-4542 (2004).
160. Sarter B, Long TI, Tsong WH, Koh WP, Yu MC, Laird PW: Sex differential in methylation patterns of selected genes in Singapore Chinese. Hum Genet 117:402-403 (2005).
161. Scholer HR, Ruppert S, Suzuki N, Chowdhury K, Gruss P: New type of POU domain in germ line-specific protein Oct-4. Nature 344:435-439 (1990).
162. Schubeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C, van Leeuwen F, Gottschling DE, O'Neill LP, Turner BM, Delrow J, et al: The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev 18:1263-1271 (2004).
163. Shiota K: DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenet Genome Res 105:325-334 (2004).
164. Shiota K, Kogo Y, Ohgane J, Imamura T, Urano A, Nishino K, Tanaka S, Hattori N: Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells 7:961-969 (2002).
165. Simon I, Barnett J, Hannett N, Harbison CT, Rinaldi NJ, Volkert TL, Wyrick JJ, Zeitlinger J, Gifford DK, Jaakkola TS, et al: Serial regulation of transcriptional regulators in the yeast cell cycle. Cell 106:697-708 (2001).
166. Smith CD, Smith DL, DeRisi JL, Blackburn EH: Telomeric protein distributions and remodeling through the cell cycle in Saccharomyces cerevisiae. Mol Biol Cell 14:556-570 (2003).
167. Solomon MJ, Varshavsky A: Formaldehyde-mediated DNA-protein crosslinking: a probe for in vivo chromatin structures. Proc Natl Acad Sci USA 82:6470-6474 (1985).
168. Song F, Smith JF, Kimura MT, Morrow AD, Matsuyama T, Nagase H, Held WA: Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc Natl Acad Sci USA 102:3336-3341 (2005).
169. Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ: Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene 21:1048-1061 (2002).
170. Spencer VA, Sun JM, Li L, Davie JR: Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. Methods 31:67-75 (2003).
171. Strichman-Almashanu LZ, Lee RS, Onyango PO, Perlman E, Flam F, Frieman MB, Feinberg AP: A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. Genome Res 12:543-554 (2002).
172. Sylvester I, Scholer HR: Regulation of the Oct-4 gene by nuclear receptors. Nucleic Acids Res 22:901-911 (1994).
173. Takai D, Jones PA: Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 99:3740-3745 (2002).
174. Takebayashi S, Sugimura K, Saito T, Sato C, Fukushima Y, Taguchi H, Okumura K: Regulation of replication at the R/G chromosomal band boundary and pericentromeric heterochromatin of mammalian cells. Exp Cell Res 304:162-174 (2005).
175. Tanaka S, Oda M, Toyoshima Y, Wakayama T, Tanaka M, Yoshida N, Hattori N, Ohgane J, Yanagimachi R, Shiota K: Placentomegaly in cloned mouse concepti caused by expansion of the spongiotrophoblast layer. Biol Reprod 65:1813-1821 (2001).
176. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96:8681-8686 (1999).
177. Tuerk C, Gold L: Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510 (1990).
178. Ushijima T: Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5:223-231 (2005).
179. Ushijima T, Okochi-Takada E: Aberrant methylations in cancer cells: Where do they come from? Cancer Sci 96:206-211 (2005).
180. Ushijima T, Sasako M: Focus on gastric cancer. Cancer Cell 5:121-125 (2004).
181. Ushijima T, Watanabe N, Shimizu K, Miyamoto K, Sugimura T, Kaneda A: Decreased fidelity in replicating CpG methylation patterns in cancer cells. Cancer Res 65:11-17 (2005).
182. van Leeuwen F, van Steensel B: Histone modifications: from genome-wide maps to functional insights. Genome Biol 6:113 (2005).
183. van Steensel B: Mapping of genetic and epigenetic regulatory networks using microarrays. Nat Genet 37 Suppl:S18-24 (2005).
184. van Steensel B, Henikoff S: Identification of in vivo DNA targets of chromatin proteins using tethered dam methyltransferase. Nat Biotechnol 18: 424-428 (2000).
185. van Steensel B, Henikoff S: Epigenomic profiling using microarrays. Biotechniques 35:346-350, 352-354, 356-357 (2003).
186. van Steensel B, Delrow J, Henikoff S: Chromatin profiling using targeted DNA adenine methyltransferase. Nat Genet 27:304-308 (2001).
187. Velicescu M, Weisenberger DJ, Gonzales FA, Tsai YC, Nguyen CT, Jones PA: Cell division is required for de novo methylation of CpG islands in bladder cancer cells. Cancer Res 62:2378-2384 (2002).
188. Verdel A, Jia S, Gerber S, Sugiyama T, Gygi S, Grewal SI, Moazed D: RNAi-mediated targeting of heterochromatin by the RITS complex. Science 303:672-676 (2004).
189. Wade JT, Hall DB, Struhl K: The transcription factor Ifh1 is a key regulator of yeast ribosomal protein genes. Nature 432:1054-1058 (2004).
190. Wakayama T, Yanagimachi R: Mouse cloning with nucleus donor cells of different age and type. Mol Reprod Dev 58:376-383 (2001).
191. Wang W, Cherry JM, Botstein D, Li H: A systematic approach to reconstructing transcription networks in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 99:16893-16898 (2002).
192. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D: Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37:853-862 (2005).
193. Weber SA, Gerton JL, Polancic JE, DeRisi JL, Koshland D, Megee PC: The kinetochore is an enhancer of pericentric cohesin binding. PLoS Biol 2:E260 (2004).
194. Weil MR, Widlak P, Minna JD, Garner HR: Global survey of chromatin accessibility using DNA microarrays. Genome Res 14:1374-1381 (2004).
195. Weinmann AS, Farnham PJ: Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 26:37-47 (2002).
196. Weinmann AS, Yan PS, Oberley MJ, Huang TH, Farnham PJ: Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 16:235-244 (2002).
197. Wells J, Yan PS, Cechvala M, Huang T, Farnham PJ: Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase. Oncogene 22:1445-1460 (2003).
198. Yamashita K, Dai T, Dai Y, Yamamoto F, Perucho M: Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 4:121-131 (2003).
199. Yoshida M, Furumai R, Nishiyama M, Komatsu Y, Nishino N, Horinouchi S: Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol 48 Suppl 1:S20-S26 (2001).
200. Yuan GC, Liu YJ, Dion MF, Slack MD, Wu LF, Altschuler SJ, Rando OJ: Genome-scale identification of nucleosome positions in S. cerevisiae. Science 309:626-630 (2005).